Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-086668
Filing Date
2025-09-11
Accepted
2025-09-11 07:49:50
Documents
2
Period of Report
2025-09-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0256954-6k_scinai.htm 6-K 20979
2 STANDBY EQUITY PURCHASE AGREEMENT, DATED AS OF SEPTEMBER 10, 2025, BETWEEN THE R ea025695401ex99-1_scinai.htm EX-99.1 235588
  Complete submission text file 0001213900-25-086668.txt   257811
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 251307236
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)